Figure 2From: Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseasesOR of congenital defects and live births. The OR for congenital defects (2A)and live births (2B) from the pooled data in the HCQ group compared to the control group was determined.Back to article page